About Prudent Bio
Prudent Bio is a company based in Bridgewater (United States) founded in 2024. It operates as a B2B and Partnership-based. Prudent Bio offers products and services including Biosimilar Therapies and Therapy Pipeline. Prudent Bio operates in a competitive market with competitors including Biogen, ADMA Biologics, Kymeratx, BioNTech and Generate Biomedicines, among others.
- Headquarter Bridgewater, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Prudentbio Research Private Limited
- Date of Incorporation 22 May, 2018
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Prudent Bio
Prudent Bio offers a comprehensive portfolio of products and services, including Biosimilar Therapies and Therapy Pipeline.
Develops lower-cost alternatives to biologic drugs for global markets.
Innovative pipeline for affordable healthcare solutions worldwide.
Funding Insights of Prudent Bio
Detailed funding history for Prudent Bio
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Prudent Bio
Investment portfolio details for Prudent Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Prudent Bio
Detailed financials for Prudent Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Prudent Bio Comparisons
Peer comparison for Prudent Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Prudent Bio
Prudent Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, ADMA Biologics, Kymeratx, BioNTech and Generate Biomedicines, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| Locked | Locked | Locked |
Plasma-based biologics are developed for immune deficiency and infectious diseases.
|
|
| Locked | Locked | Locked |
Small molecule protein degraders are developed for various disorders.
|
|
| Locked | Locked | Locked |
Immunotherapeutics for cancer and other diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| Locked | Locked | Locked |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
Detailed competitors of Prudent Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Prudent Bio
Complete news archive for Prudent Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prudent Bio
Prudent Bio was founded in 2024.
Prudent Bio is headquartered in Bridgewater, United States. It is registered at Bridgewater, New Jersey, United States.
Prudent Bio is a biopharmaceutical company focused on creating affordable therapies to improve global healthcare access. It achieves this by developing biosimilars and exploring partnerships, including licensing deals and strategic alliances. Based in Bridgewater, New Jersey, USA, the company aims to benefit patients through innovative pipelines and shared-profit ventures. Its activities emphasize cost reduction in therapeutics without compromising quality.
Prudent Bio's top competitors include ADMA Biologics, BioNTech and Vera Therapeutics.
Prudent Bio offers Biosimilar Therapies and Therapy Pipeline.